Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization

BACKGROUND: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). However, limited studies have investigated the safety and effectiveness of SABR in patients with advanced diseases that is unsuitable for transar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Med Oncol
Autores principales: Lee, Hsin-Lun, Tsai, Jo-Ting, Chen, Chun-You, Lin, Ying-Chun, Ho, Chin-Beng, Ting, Lai-Lei, Kuo, Chia-Chun, Lai, I-Chun, Lin, Chun-Yu, Tang, Jui-Hsiang, Huang, Yu-Min, Kao, Wei-Yu, Cheng, Sheng-Wei, Shen, Chia-Ning, Chen, Shang-Wen, Chiou, Jeng-Fong
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2019
Materias:
Early Diagnosis and Therapeutic Advances for Liver Cancer: From Bench to Bedside
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6893933/
https://ncbi.nlm.nih.gov/pubmed/31839809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919889002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares